glp-1 weight loss drugs Patients' Use for Loss, Benefit Gains GLP-1 weight loss drugs may

While Bydureon BCise is not a weight loss medication, study participants lost an average of 3 pounds

These conditions may also be managed with lifestyle adjustments like diet changes in many instances

doi: 10.1007/s13300-019-00735-7

As production struggles to keep up, the pharma industry is now focusing on the upcoming patent expiry of key GLP-1 drugs like semaglutide, expected to start in early 2026 in countries like India, Brazil, China, and Canada (some reports even suggest 2025)

60 The study demonstrated GLP1s ability to prevent atrial electrical and structural remodelling, crucial in new-onset and established AF

Dhungana S, Sharrack B, Woodroofe N